General Information


DRAVP ID  DRAVPe01722

Peptide Name   P1(SARS-CoV (1153-1189))

Sequence  GINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE

Sequence Length  37

UniProt ID  P59594 

Taxon ID  None

Source  Synthetic construct

Validation   Experimentally Validated



Origin Information


Gene Name/ID  Not Available

GenBank  Not Available

Amino Acid position  Not Available

Domain Accession ID  Not Available

Nucleotide sequence ID  Not Available

Molecular Type  Not Available

Chromosomal Position  Not Available



Activity Information


Target Organism  SARS-CoV

Assay  cell fusion inhibition assay

Activity 

  • [Ref.18983873]SARS-CoV:inhibition of cell fusion in Hela cells (IC50=0.62 ± 0.20 μM);inhibition of SARS-CoV infection in Vero-E6 cells (IC50=3.04 ± 0.06 μM).
  • [Ref.15043961]SARS-CoV:inhibition of the cytopathic effect in Vero E6 cells(IC50~19 μM/L).

Hemolytic Activity  No hemolysis information or data found in the reference(s) presented in this entry

Cytotoxicity 

  • [Ref.18983873]No discernable cytotoxicity on HeLa or VeroE6 cells at the concentrations of 25 μM.

Binding Target  membrane

Mechanism  Binding to the HR1 region and blocking the formation of a 6-helix bundle during the fusion step of virus entry, thus inhibiting virus entry.



Structure Information


PDB ID  None

Predicted Structure Download  No predicted structure available

Linear/Cyclic  Linear

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Stereochemistry  L



Physicochemical Information


Formula  C181H302N50O62

Absent amino acids  CFHMPTW

Common amino acids  ELN

Mass  4170.69

Pl  4.49

Basic residues  4

Acidic residues  7

Hydrophobic residues  14

Net charge  -3

Boman Index  -7238

Hydrophobicity  -42.43

Aliphatic Index  123.78

Half Life 

  •     Mammalian:30 hour
  •     Yeast:>20 hour
  •     E.coli:>10 hour

Extinction Coefficient cystines  1490

Absorbance 280nm  41.39

Polar residues  10



Literature Information


Literature 1

Title   Identification of a minimal peptide derived from heptad repeat (HR) 2 of spike protein of SARS-CoV and combination of HR1-derived peptides as fusion inhibitors.

Pubmed ID   18983873

Reference   Antiviral Res. 2009 Jan;81(1):82-7.

Author   Liu IJ, Kao CL, Hsieh SC, Wey MT, Kan LS, Wang WK.

DOI   10.1093/infdis/jiv325.

Literature 2

Title   Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors.

Pubmed ID   15043961

Reference   Lancet. 2004 Mar 20;363(9413):938-47.

Author   Liu S, Xiao G, Chen Y, He Y, Niu J, Escalante CR, Xiong H, Farmar J, Debnath AK, Tien P, Jiang S.

DOI   10.1016/j.antiviral.2008.10.001.